Puma Biotechnology Reports Second Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St set for tepid open as oil prices fall, Treasury yields rise
- Oil prices edge lower on easing fears over Saudi supply disruption
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Puma Biotech (PBYI) Tops Q2 EPS, Revenues Miss
August 5, 2021 5:51 PM EDTPuma Biotech (NASDAQ: PBYI) reported Q2 EPS of $0.32, $0.34 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $48.9 million versus the consensus estimate of $51.6 million.
Net cash used in operating activities for the second quarter of 2021 was $0.1 million, compared to... More
